Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Cytoplasmic and Nuclear Receptors. Found 6 abstracts

Li C, Andrake M, Dunbrack R, Enders GH. A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export. Mol Cell Biol. 2010 Jan;30(1):116-30.   PMCID: PMC2798281
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Badawi AF, Badr MZ. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review). Int J Oncol. 2002 Jun;20(6):1109-22.
Seggerson K, Tang L, Moss EG. Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev Biol. 2002 Mar 15;243(2):215-25.
Yang WL, Frucht H. Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis. 2001 Sep;22(9):1379-83.
Einarson MB, Golemis EA. Encroaching genomics: adapting large-scale science to small academic laboratories. Physiol Genomics. 2000 Apr 27;2(3):85-92.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Cytoplasmic and Nuclear Receptors

Cytoplasmic and Nuclear Receptors physiology genetics Isoenzymes Transcription Factors Prostaglandin-Endoperoxide Synthase Cyclooxygenase Inhibitors metabolism Human Conserved Sequence Cell Cycle Animal Apoptosis biosynthesis US Gov't Support-PHS pharmacology Drug Synergism antagonists & inhibitors Female enzymology Caenorhabditis elegans Cell Division 0 (Sulfonamides) 41598-07-6 (Prostaglandin D2) Developmental Gene Expression Regulation 0 (Fluorenes) ai [Antagonists & Inhibitors] prevention & control Methylnitrosourea bi [Biosynthesis] Dinoprostone 0 (15-deoxyprostaglandin J2) Density Gradient Centrifugation en [Enzymology] Messenger RNA G2 Phase 0 (Anticarcinogenic Agents) Prostaglandins growth & development Cyclin E Sprague-Dawley Rats Enzyme-Linked Immunosorbent Assay Karyopherins Human Genome Project Non-Steroidal Anti-Inflammatory Agents Genetic Complementation Test Peptide Chain Initiation drug effects cytology 363-24-6 (Dinoprostone) Protein-Serine-Threonine Kinases Amino Acid Sequence Mitosis Phosphorylation Prostaglandin D2 methods Molecular Sequence Data Helminth Proteins 0 (Isoenzymes) Comparative Study ci [Chemically Induced] Sulfonamides 0 (Transcription Factors) Cell Nucleus me [Metabolism] Cell Cycle Proteins cdc Genes ad [Administration & Dosage] Ribosomes Down-Regulation RNA Interference US Gov't Support-Non-PHS agonists Genetically Modified Animals Antineoplastic Agents EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) United States Laboratories Protein Synthesis Inhibitors Thiazoles pd [Pharmacology] 61-90-5 (Leucine) de [Drug Effects] pc [Prevention & Control] Drosophila Genomics Saccharomyces cerevisiae Cycloheximide Peptide Chain Elongation Protein-Tyrosine Kinases Cyclin-Dependent Kinase 2 DNA Fragmentation Anticarcinogenic Agents Chromosome Mapping Research Design economics Nuclear Proteins S Phase Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) Genetic Models Protein Binding ag [Agonists] organization & administration Fluorenes inhibitors 169590-42-5 (celecoxib) Repressor Proteins HT29 Cells 0 (Cyclooxygenase Inhibitors) Computational Biology Research Caenorhabditis elegans Proteins 684-93-5 (Methylnitrosourea) Rats chemistry Tretinoin Cyclin A aa [Analogs & Derivatives] Proteome Breast Neoplasms EC 1-14-99-1 (cyclooxygenase 2) Amino Acid Motifs trends Leucine Larva Cell Line therapeutic use ph [Physiology] Two-Hybrid System Techniques Cell Nucleus Active Transport Tertiary Protein Structure Factual Databases antagonists & Post-Translational Protein Processing Carcinogens 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Experimental Mammary Neoplasms
Last updated on Friday, August 14, 2020